NCT04085380 (CODBAHRE) is a clinical trial in Risk Factor, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT04085380?

NCT04085380 is sponsored by Assistance Publique - Hôpitaux de Paris.

What condition does NCT04085380 study?

NCT04085380 studies Risk Factor.

Is NCT04085380 still recruiting?

NCT04085380 is currently completed. Last updated 8 October 2020.

Last reviewed 2020-10-08 · How we verify

NCT04085380: CODBAHRE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Digestive Colonisation by Highly Resistant Bacteria (CODBAHRE)

Completed Last updated 8 October 2020

What this trial tests

trial in Risk Factor in 2,396 participants. Completed in 10 July 2020.

Timeline

16 September 2019

Primary endpoint
16 January 2020

10 July 2020

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Completed
Study type	OBSERVATIONAL
Enrollment	2,396
Start date	16 September 2019
Primary completion	16 January 2020
Estimated completion	10 July 2020
Sites	1 location across France

Conditions studied

Risk Factor — all drugs for Risk Factor →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

Eligibility, any sex, with Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to identify in hospitalized patients, the risk factors associated with the digestive colonisation by emergent extensively drug-resistant bacteria (eXDR), to optimize their detection and the medical care for carriers these patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04085380 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 8 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04085380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing